Pediatric Rheumatology Division, Instituto de Puericultura e Pediatria Martagão Gesteira/Federal University of Rio de Janeiro, Rua Silva Ramos, 166/apto 403-Tijuca, Rio de Janeiro 20270-330, Brazil.
Rheumatol Int. 2013 Jul;33(7):1873-8. doi: 10.1007/s00296-011-2336-6. Epub 2012 Jan 1.
Relapsing polychondritis (RP) is a rare autoimmune systemic disease, especially in childhood. To report three new pediatric RP cases, to provide a literature review and to compare with adulthood disease, retrospective data collection from three childhood RP cases was observed in a Brazilian Pediatric Rheumatology Division. A literature review based on a MEDLINE database search was performed. Arthritis and auricular chondritis were present in our three patients. Two cases presented with early and severe laryngotracheal chondritis, besides initial and symptomatic costochondritis. The other case developed prominent epiphyseal plate involvement. Two patients were refractory to corticosteroids and immunosuppressants and required the use of TNF-alpha inhibitors to improve the symptoms, while corticosteroids plus methotrexate induced remission in the other patient. The literature review showed 44 cases of pediatric-onset disease in English language. Arthritis and ear chondritis are the most common initial and cumulative manifestations of RP in children and adults. Nasal and laryngotracheobronchial chondritis are also common manifestations observed during follow-up in childhood. There is also an early severity of respiratory chondritis in childhood, requiring aggressive treatment with corticosteroids, immunosuppressants and biologic agents. The data presented by those 3 children, considered in conjunction with the data from the 44 published cases, may reflect some distinguishing childhood RP features, such as more severe and frequent respiratory tract involvement, symptomatic costochondritis and the atypical pattern of persistent and destructive arthritis with epiphyseal plate involvement. Response to immunosuppressants and biologic agents is anecdotal, but steroids remain the main drug during the flares.
复发性多软骨炎(RP)是一种罕见的自身免疫性系统性疾病,尤其在儿童中更为罕见。为了报告三例新的儿科 RP 病例,提供文献复习并与成人疾病进行比较,我们观察了巴西儿科风湿病科的三例儿童 RP 病例的回顾性数据收集。进行了基于 MEDLINE 数据库搜索的文献复习。我们的三例患者均存在关节炎和耳软骨炎。两例患者早期和严重的喉气管软骨炎,以及初始和症状性肋软骨炎。另一个病例则出现了明显的骺板受累。两例患者对皮质类固醇和免疫抑制剂耐药,需要使用 TNF-α 抑制剂来改善症状,而另一名患者则使用皮质类固醇加甲氨蝶呤诱导缓解。文献复习显示,英语中有 44 例儿科发病的病例。关节炎和耳部软骨炎是儿童和成人 RP 最常见的初始和累积表现。鼻和喉气管支气管软骨炎也是儿童随访期间常见的表现。儿童也存在早期严重的呼吸道软骨炎,需要积极使用皮质类固醇、免疫抑制剂和生物制剂进行治疗。这 3 名儿童的数据,结合 44 例已发表病例的数据,可能反映了儿童 RP 的一些独特特征,如更严重和频繁的呼吸道受累、症状性肋软骨炎以及伴有骺板受累的持续性和破坏性关节炎的非典型模式。对免疫抑制剂和生物制剂的反应是偶发的,但在疾病发作时类固醇仍然是主要药物。